Influence of medications and diagnoses on fall risk in psychiatric inpatients
- Psychiatry Revisited. Dean, Charles E. // Minnesota Medicine;Mar2008, Vol. 91 Issue 3, p41
The author examines the development in the diagnosis and treatment of psychiatric disorders in Minnesota. It is evident that researchers and medical practitioners have a full understanding on how the brain works as well as the development of antipsychotic agents and antidepressants. However,...
- Rethink Depression. MAISEL, ERIC // Natural Solutions;Jul/Aug2012, Issue 145, p58
The article discusses phenomena of depression and compares it with sign of sadness. It states that the antidepressant chemical which are effective in changing mood may not be an appropriate treatment for depression. It focuses on authentic living where what matters to an individual, his thoughts...
- Serious mental illness. Shergill, Sukhi; Tracy, Derek // Pulse;5/25/2011, Vol. 71 Issue 19, p21
The article offers information on the management and treatment of patients suffering from serious mental illness including schizophrenia, bipolar affective disorder, and schizoaffective disorders. It details the prevalence, symptoms, and treatment of mental disorders as well as the monitoring of...
- RevisiÃ³n de la historia del trastorno esquizoafectivo y su relaciÃ³n con los rasgos de personalidad. Borrero, Álvaro Arenas; Prada, Adriana Rogelis // Universitas MÃ©dica;abr-jun2006, Vol. 47 Issue 2, p147
We present a literary revision of the history of schizoaffective disorder and his place in the modern diagnosis classification system. We address the importance of personality traits in the diagnosis and management of schizoaffective disorder, we review also the importance of the study of...
- Tests, testing, and tested - we need to critically evaluate the meaning of tests in psychiatry. Berger, Douglas M. // Indian Journal of Psychiatry;Apr-Jun2013, Vol. 55 Issue 2, p200
This article describes clinical pitfalls in our concepts of what it means for an illness, diagnosis, or evaluation and treatment methods to say that they have been "tested". This articles begins with the problems encountered in newborn testing for Krabbe Disease of the nervous system in New York...
- Olanzapine versus haloperidol in the treatment of schizoaffective disorder. Iran, Pierre V.; Tollefson, Gary D.; Sanger, Todd M.; Yili Lu; Berg, Paul H.; Beasley Jr., Charles M. // British Journal of Psychiatry;Jan99, Vol. 174, p15
Background The effectiveness of antipsychotic monotherapy in schIzoaffective disorder is limited, and further constrained by safety concerns. Aims We aimed to compare the efficacy, tolerability and safety profile of the new pharmaceutical, olanzapine, with haloperidol. Method Data were assessed...
- Psychological Medicine. Gilbert, John C. // British Medical Journal;4/10/1976, Vol. 1 Issue 6014, p882
Focuses on the drugs used in treating psychological disorders. Discovery of the potent antipsychotic agent, haloperidol; Powerful tranquilizing effect of reserpine; Effectiveness of tricyclic antidepressants in treating depressive illness.
- Will the new antipsychotics improve the treatment of schizophrenia? Hale, Tony // BMJ: British Medical Journal (International Edition);9/25/93, Vol. 307 Issue 6907, p749
Focuses on the impact of non-compliance with neuroleptic treatment to the success of treatment for mental illness. Emphasis in minimization of extrapyramidal side effects; Improvement of compliance through creative approaches; Role of drug related depression and psychological factors on compliance.
- Brain circuitry model will transform mental health research. White, Caroline // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;9/10/2011, Vol. 343 Issue 7822, p500
The article reports on the revelation of the U.S. National Institute of Mental Health regarding the transformation mental health services to better provide diagnosis and treatment of such disease, as well as improve the lack of major progress in the field.